LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea flag South Korea · Delayed Price · Currency is KRW
114,300
-200 (-0.17%)
May 30, 2025, 1:40 PM KST

LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 51.58B KRW in the quarter ending March 31, 2025, with 66.07% growth. This brings the company's revenue in the last twelve months to 146.42B, up 154.45% year-over-year. In the year 2024, LigaChem Biosciences had annual revenue of 125.90B with 268.71% growth.

Revenue (ttm)
146.42B
Revenue Growth
+154.45%
P/S Ratio
28.37
Revenue / Employee
898.27M
Employees
163
Market Cap
4,154.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024125.90B91.75B268.71%
Dec 31, 202334.15B733.60M2.20%
Dec 31, 202233.41B1.26B3.90%
Dec 31, 202132.16B-25.34B-44.07%
Dec 31, 201957.50B32.26B127.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
Peptron 3.15B
PharmaResearch 392.31B
Revenue Rankings